These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 22177633)

  • 21. Diagnosis of latent tuberculosis infection in bacille Calmette-Guérin vaccinated subjects in China by interferon-gamma ELISpot assay.
    Zhang M; Wang H; Liao M; Chen X; Graner M; Zhu X; Zhang J; Yang Q; Lu H; Zhou B; Chen X
    Int J Tuberc Lung Dis; 2010 Dec; 14(12):1556-63. PubMed ID: 21144240
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guidelines on interferon-γ release assays for tuberculosis infection: concordance, discordance or confusion?
    Denkinger CM; Dheda K; Pai M
    Clin Microbiol Infect; 2011 Jun; 17(6):806-14. PubMed ID: 21682801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical application and limitations of interferon-gamma release assays for the diagnosis of latent tuberculosis infection.
    Herrera V; Perry S; Parsonnet J; Banaei N
    Clin Infect Dis; 2011 Apr; 52(8):1031-7. PubMed ID: 21460320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New tests will improve detection of latent TB.
    Chapman AL
    Practitioner; 2011 Nov; 255(1745):23-6, 2-3. PubMed ID: 22235551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Mycobacterium tuberculosis infection: signification, role and performance of mesure of cell-mediated immune response].
    Glardon D; Erard V
    Rev Med Suisse; 2014 Apr; 10(425):816-9. PubMed ID: 24791428
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interferon-gamma release assays versus tuberculin skin testing in patients with rheumatoid arthritis.
    Song GG; Bae SC; Lee YH
    Int J Rheum Dis; 2013 Jun; 16(3):279-83. PubMed ID: 23981748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictive value of interferon-γ release assays and tuberculin skin testing for progression from latent TB infection to disease state: a meta-analysis.
    Diel R; Loddenkemper R; Nienhaus A
    Chest; 2012 Jul; 142(1):63-75. PubMed ID: 22490872
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [New recommendations for contact tracing in tuberculosis].
    Diel R; Loytved G; Nienhaus A; Castell S; Detjen A; Geerdes-Fenge H; Haas W; Hauer B; Königstein B; Maffei D; Magdorf K; Priwitzer M; Zellweger JP; Loddenkemper R
    Gesundheitswesen; 2011 Jun; 73(6):369-88. PubMed ID: 21695661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A prospective large-scale study of methods for the detection of latent Mycobacterium tuberculosis infection in refugee children.
    Lucas M; Nicol P; McKinnon E; Whidborne R; Lucas A; Thambiran A; Burgner D; Waring J; French M
    Thorax; 2010 May; 65(5):442-8. PubMed ID: 20435869
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnosis of tuberculosis infection by interferon-gamma release assays in patients with psoriasis.
    Latorre I; Carrascosa JM; Vilavella M; Díaz J; Prat C; Domínguez J; Ferrándiz C
    J Infect; 2014 Dec; 69(6):600-6. PubMed ID: 25148944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Latent tuberculosis infections in hard-to-reach drug using population-detection, prevention and control.
    Hwang LY; Grimes CZ; Beasley RP; Graviss EA
    Tuberculosis (Edinb); 2009 Dec; 89 Suppl 1():S41-5. PubMed ID: 20006303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of interferon {gamma} release assays and conventional screening tests before tumour necrosis factor {alpha} blockade in patients with inflammatory arthritis.
    Martin J; Walsh C; Gibbs A; McDonnell T; Fearon U; Keane J; Codd MB; Dodd J; Veale D; Fitzgerald O; Bresnihan B
    Ann Rheum Dis; 2010 Jan; 69(1):181-5. PubMed ID: 19176545
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [New recommendations for contact tracing in tuberculosis. German Central Committee against Tuberculosis].
    Diel R; Loytved G; Nienhaus A; Castell S; Detjen A; Geerdes-Fenge H; Haas W; Hauer B; Königstein B; Maffei D; Magdorf K; Priwitzer M; Zellweger JP; Loddenkemper R
    Pneumologie; 2011 Jun; 65(6):359-78. PubMed ID: 21560113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection in hemodialysis patients.
    Seyhan EC; Sökücü S; Altin S; Günlüoğlu G; Trablus S; Yilmaz D; Koksalan OK; Issever H
    Transpl Infect Dis; 2010 Apr; 12(2):98-105. PubMed ID: 19903322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon-γ release assays for diagnosis of latent tuberculosis infection: evidence in immune-mediated inflammatory disorders.
    Smith R; Cattamanchi A; Steingart KR; Denkinger C; Dheda K; Winthrop KL; Pai M
    Curr Opin Rheumatol; 2011 Jul; 23(4):377-84. PubMed ID: 21519268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advances in the diagnosis of latent tuberculosis infection.
    Schluger NW
    Semin Respir Crit Care Med; 2013 Feb; 34(1):60-6. PubMed ID: 23460006
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New tools and emerging technologies for the diagnosis of tuberculosis: part I. Latent tuberculosis.
    Pai M; Kalantri S; Dheda K
    Expert Rev Mol Diagn; 2006 May; 6(3):413-22. PubMed ID: 16706743
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performance of the tuberculin skin test and interferon-γ release assays: an update on the accuracy, cutoff stratification, and new potential immune-based approaches.
    Goletti D; Sanduzzi A; Delogu G
    J Rheumatol Suppl; 2014 May; 91():24-31. PubMed ID: 24788997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Latent tuberculosis infection in psoriasis and other dermatological immunomediated diseases: a combined approach by QuantiFERON-TB Gold and tuberculin skin tests.
    Prignano F; Bartoloni A; Bartalesi F; Gori A; Ricceri F; Cavallo A; Attala L; Mantella A
    Int J Dermatol; 2014 Aug; 53(8):e372-4. PubMed ID: 24898978
    [No Abstract]   [Full Text] [Related]  

  • 40. Is tuberculin skin testing reliable during anti-tumor necrosis factor-alfa therapy? A case report and review of the literature.
    Haddican MM; Koo JY
    J Am Acad Dermatol; 2011 Jul; 65(1):195-7. PubMed ID: 21507516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.